| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 9346 | 2021 |
| Natural products in drug discovery: advances and opportunities AG Atanasov, SB Zotchev, VM Dirsch, CT Supuran Nature reviews Drug discovery 20 (3), 200-216, 2021 | 1233 | 2021 |
| The anti-malarial artesunate is also active against cancer T Efferth, H Dunstan, A Sauerbrey, H Miyachi, CR Chitambar International journal of oncology 18 (4), 767-773, 2001 | 864 | 2001 |
| From traditional Chinese medicine to rational cancer therapy T Efferth, PCH Li, VSB Konkimalla, B Kaina Trends in molecular medicine 13 (8), 353-361, 2007 | 587 | 2007 |
| Antimicrobial activity of clove and rosemary essential oils alone and in combination YJ Fu, YG Zu, LY Chen, XG Shi, Z Wang, S Sun, T Efferth Phytotherapy research 21 (10), 989-994, 2007 | 583 | 2007 |
| Molecular modes of action of artesunate in tumor cell lines T Efferth, A Sauerbrey, A Olbrich, E Gebhart, P Rauch, HO Weber, ... Molecular pharmacology 64 (2), 382-394, 2003 | 566 | 2003 |
| The antiviral activities of artemisinin and artesunate T Efferth, MR Romero, DG Wolf, T Stamminger, JJG Marin, M Marschall Clinical infectious diseases 47 (6), 804-811, 2008 | 516 | 2008 |
| Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy T Efferth, E Koch Current drug targets 12 (1), 122-132, 2011 | 495 | 2011 |
| Chemotherapy-induced resistance by ATP-binding cassette transporter genes JP Gillet, T Efferth, J Remacle Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1775 (2), 237-262, 2007 | 452 | 2007 |
| The role of p53 in cancer drug resistance and targeted chemotherapy K Hientz, A Mohr, D Bhakta-Guha, T Efferth Oncotarget 8 (5), 8921, 2017 | 425 | 2017 |
| From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy T Efferth Seminars in cancer biology 46, 65-83, 2017 | 407 | 2017 |
| Molecular principles of cancer invasion and metastasis MF Leber, T Efferth International journal of oncology 34 (4), 881-895, 2009 | 364 | 2009 |
| Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron T Efferth, A Benakis, MR Romero, M Tomicic, R Rauh, D Steinbach, ... Free Radical Biology and Medicine 37 (7), 998-1009, 2004 | 364 | 2004 |
| Activities of Ten Essential Oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 Cancer Cells Y Zu, H Yu, L Liang, Y Fu, T Efferth, X Liu, N Wu Molecules 15 (5), 3200-3210, 2010 | 363 | 2010 |
| Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells T Efferth Current drug targets 7 (4), 407-421, 2006 | 341 | 2006 |
| Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin-from bench to bedside T Efferth Planta medica 73 (04), 299-309, 2007 | 306 | 2007 |
| Antibacterial Activity and Anticancer Activity of Rosmarinus officinalis L. Essential Oil Compared to That of Its Main Components W Wang, N Li, M Luo, Y Zu, T Efferth Molecules 17 (3), 2704-2713, 2012 | 302 | 2012 |
| Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system MR Romero, T Efferth, MA Serrano, B Castaño, RIR Macias, O Briz, ... Antiviral research 68 (2), 75-83, 2005 | 299 | 2005 |
| Activity of drugs from traditional Chinese medicine toward sensitive and MDR1-or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells T Efferth, M Davey, A Olbrich, G Rücker, E Gebhart, R Davey Blood Cells, Molecules, and Diseases 28 (2), 160-168, 2002 | 299 | 2002 |
| Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate R Dell’Eva, U Pfeffer, R Vené, L Anfosso, A Forlani, A Albini, T Efferth Biochemical pharmacology 68 (12), 2359-2366, 2004 | 296 | 2004 |
